Immutep (ASX:IMM) - Key People

ASX:IMM · Directors, executives and key personnel · 12 month lookback

Marc Voigt Current

Chief Executive Officer & Executive Director

Mentioned in

Immutep Reports Mature 30.9-Month Survival in 1L NSCLC but TACTI-004 Trial Halted

13 July 2026

Market Wrap - Week 16 (13 Apr -> 17 Apr) 2026

18 Apr 2026

Healthcare Wrap - Week 16 (13 Apr -> 17 Apr) 2026

18 Apr 2026

Immutep Secures FDA Orphan Drug Status for Eftilagimod Alfa in Soft Tissue Sarcoma

15 Apr 2026

+13 more articles →

Also Mentioned

People named in Immutep (ASX:IMM) articles over the last 12 months, by frequency.

Frédéric Triebel · 5 articles med. Akin Atma · 4 articles Nuhad Ibrahim · 4 articles Reddy’s Laboratories SA · 3 articles Katarzyna Kozak, M.D. · 3 articles Paweł Sobczuk, M.D. · 3 articles Deanne Miller · 2 articles Chris Basta · 2 articles Eleanor Pearson · 2 articles Stephan Winckels M.D · 2 articles Christian Mueller · 2 articles Stephan Winckels · 2 articles Paweł Sobczuk · 1 article Pavani Chalasani, MD, MPH · 1 article Katarzyna Kozak · 1 article Russell Howard · 1 article Pete Meyers · 1 article Lis Boyce · 1 article Anne Anderson · 1 article Florian Vogl · 1 article